HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myoblast sheet can prevent the impairment of cardiac diastolic function and late remodeling after left ventricular restoration in ischemic cardiomyopathy.

AbstractBACKGROUND:
Impairment of diastolic function and late remodeling are concerns after left ventricular restoration (LVR) for ischemic cardiomyopathy. This study aims to evaluate the effects of combined surgery of myoblast sheets (MS) implantation and LVR.
METHODS:
Rat myocardial infarction model was established 2 weeks after left anterior descending artery ligation. They were divided into three groups: sham operation (n=15; group sham), LVR by plicating the infracted area (n=15; group LVR), and MS implantation with LVR (n=15; group LVR+MS).
RESULTS:
Serial echocardiographic study revealed significant LV redilatation and decrease of ejection fraction 4 weeks after LVR in group LVR. MS implantation combined with LVR prevented those later deteriorations of LV function in group LVR+MS. Four weeks after the operation, a hemodynamic assessment using a pressure-volume loop showed significantly preserved diastolic function in group LVR+MS; end-diastolic pressure (LVR vs. LVR+MS: 9.0±6.6 mm Hg vs. 2.0±1.0 mm Hg, P<0.05), end-diastolic pressure-volume relationship (LVR vs. LVR+MS 42±23 vs. 13±6, P<0.05). Histological examination revealed cellular hypertrophy and LV fibrosis were significantly less and vascular density was significantly higher in group LVR+MS than in the other two groups. Reverse transcription polymerase chain reaction demonstrated significantly suppressed expression of transforming growth factor-beta, Smad2, and reversion-inducing cysteine-rich protein with Kazal motifs in group LVR+MS.
CONCLUSIONS:
MS implantation decreased cardiac fibrosis by suppressing the profibrotic gene expression and attenuated the impairment of diastolic function and the late remodeling after LVR. It is suggesting that MS implantation may improve long-term outcome of LVR for ischemic heart disease.
AuthorsShunsuke Saito, Shigeru Miyagawa, Taichi Sakaguchi, Yukiko Imanishi, Hiroko Iseoka, Hiroyuki Nishi, Yasushi Yoshikawa, Satsuki Fukushima, Atsuhiro Saito, Tatsuya Shimizu, Teruo Okano, Yoshiki Sawa
JournalTransplantation (Transplantation) Vol. 93 Issue 11 Pg. 1108-15 (Jun 15 2012) ISSN: 1534-6080 [Electronic] United States
PMID22499149 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Biomarkers
  • GPI-Linked Proteins
  • Reck protein, rat
  • Smad2 Protein
  • Smad2 protein, rat
  • Transforming Growth Factor beta
  • Tumor Suppressor Proteins
Topics
  • Animals
  • Biomarkers (metabolism)
  • Chronic Disease
  • Diastole
  • Female
  • GPI-Linked Proteins (metabolism)
  • Graft Survival
  • Heart Ventricles (metabolism, pathology, physiopathology, surgery)
  • Male
  • Myoblasts, Skeletal (transplantation)
  • Myocardial Infarction (physiopathology, surgery)
  • Random Allocation
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Smad2 Protein (metabolism)
  • Transforming Growth Factor beta (metabolism)
  • Treatment Outcome
  • Tumor Suppressor Proteins (metabolism)
  • Ventricular Function, Left
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: